Dr. Karen L. Reckamp on Germline Mutations and Onset of Lung Adenocarcinoma in Smokers and Nonsmokers
Cancer Network spoke with Karen L. Reckamp, MD, of  City of Hope, about the link between several gene mutations and lung cancer in smokers vs nonsmokers. (Source: CancerNetwork)
Source: CancerNetwork - June 12, 2019 Category: Cancer & Oncology Authors: Karen L. Reckamp, MD Source Type: news

Does Oxaliplatin Improve Survival Over Cisplatin in Advanced Gastric Cancer?
Researchers tested the novel oral fluoropyrimidine derivative S-1 plus oxaliplatin vs S-1 plus cisplatin in patients with diffuse-type or mixed-type advanced gastric adenocarcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 3, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news

NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe
(NRG Oncology) Results from the first experimental arm using veliparib as part of total neoadjuvant therapy (induction chemotherapy followed by chemoradiotherapy and surgery; TNT) in patients with locally advanced rectal adenocarcinoma on the NRG Oncology Phase II clinical trial NRG-GI002 were recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2019 Category: Cancer & Oncology Source Type: news

Case: Sinonasal Adenocarcinoma Secondary to Breast Lesion Case: Sinonasal Adenocarcinoma Secondary to Breast Lesion
This unusual case highlights the differential diagnosis of invasive fungal sinusitis versus metastasis with sinus invasion, which can be difficult to differentiate by radiographic appearance.Applied Radiology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 31, 2019 Category: Allergy & Immunology Tags: Radiology Journal Article Source Type: news

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
Likelihood of cancer - directed therapy higher for first consult with medical, radiation oncology versus surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 28, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
TUESDAY, May 28, 2019 -- Many patients with noncurable pancreatic adenocarcinoma do not have a specialized cancer consultation and most do not receive cancer-directed therapy, according to a study published online May 27 in CMAJ, the journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 28, 2019 Category: Pharmaceuticals Source Type: news

Cervical Adenocarcinoma Rates Increased in Some Populations
Increasing and stabilizing incidence trends seen for several subpopulations; declines attenuated in SCC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 2, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Cervical Adenocarcinoma Rates Increased in Some Populations
THURSDAY, May 2, 2019 -- Many populations have increasing or stabilized incidence trends in cervical adenocarcinoma (AC), according to a study published in the June issue of Preventive Medicine. Farhad Islami, M.D., Ph.D., from the American Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2019 Category: Pharmaceuticals Source Type: news

Can radiomics detect pancreatic ductal adenocarcinoma?
Radiomics and a machine-learning algorithm can differentiate pancreatic ductal...Read more on AuntMinnie.comRelated Reading: AI, radiomics can help predict chemotherapy response AI may predict lymph node metastasis in gastric cancer AI can predict breast cancer molecular subtypes on MRI Russian AI detects lung cancer on CT in 20 seconds AI reliably characterizes pulmonary nodules on CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2019 Category: Radiology Source Type: news

Gene Signature Linked to Survival After Pancreatic-Cancer Surgery Gene Signature Linked to Survival After Pancreatic-Cancer Surgery
In patients with pancreatic ductal adenocarcinoma (PDAC) presence of two single-nucleotide polymorphisms (SNPs) may help predict surgical outcome, according to European researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 18, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

City of Hope scientists are using combination immunotherapy to treat advanced cancers
(City of Hope) City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly-impossible-to-treat cancer into a disease that can be corralled into remission. Daneng Li, M.D., is treating patients with advanced liver (hepatocellular) cancer, while Joseph Chao, M.D., is treating patients with advanced stomach and esophageal cancer (gastric and gastroesophageal junction adenocarcinoma). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 8, 2019 Category: Cancer & Oncology Source Type: news

Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 4, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Surgery, Journal, Source Type: news

Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
THURSDAY, April 4, 2019 -- Three factors can predict survival in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 2 in the Annals of Surgery. Mark... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 4, 2019 Category: Pharmaceuticals Source Type: news

Favorable Results Seen With APX005M in Combination Therapy for Metastatic Ductal Pancreatic Adenocarcinoma
Cancer Network spoke with Mark H. O ' Hara, MD, about the safety and efficacy of APX005M in combination with standard chemotherapy with or without nivolumab. (Source: CancerNetwork)
Source: CancerNetwork - April 4, 2019 Category: Cancer & Oncology Authors: Mark H. O & #039;Hara, MD Source Type: news

Tumor microenvironment analyzed to increase effectiveness of preclinical trials
(Kazan Federal University) It was shown that co-culturing HeLa adenocarcinoma cells, peripheral blood mononuclear cells, and mesenchymal stromal cells results in changes in the proliferative activity of the peripheral blood mononuclear cells and mesenchymal stromal cell populations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2019 Category: Cancer & Oncology Source Type: news